{
    "title": "RNA may also control Vitamin D metabolism (cancers, etc)",
    "slug": "rna-may-also-control-vitamin-d-metabolism-cancers-etc",
    "aliases": [
        "/RNA+may+also+control+Vitamin+D+metabolism+cancers+etc+\u2013+May+2021",
        "/12592"
    ],
    "tiki_page_id": 12592,
    "date": "2021-05-21",
    "tags": [
        "brain",
        "breast cancer",
        "cancer",
        "cancer in VDR",
        "cognitive",
        "colon cancer",
        "genetics",
        "lung cancer",
        "melanoma",
        "ovarian cancer",
        "skin cancer",
        "vitamin d",
        "vitamin d receptor"
    ]
}


#### Vitamin D regulation of and by long non coding RNAs

Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2021.111317

Daniel D.Bikle12

 **Highlights** 

1.LncRNAs and VDR each regulate numerous biochemical and genomic processes

2.Deletion of VDR shifts lncRNA expression to an oncogenic profile

3.Some lncRNAs can alter VDR expression or transcriptional activity

4.Different cancers show distinct VDR/lncRNA interactions and associations

<div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">

 **VitaminDWiki bought the PDF - but cannot post it online** 

Wonder how much of the variation of Vitamin D response and benefit is due to changes in RNA.

 **See also:** 

* Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2 - March 2020 [Free PDF](10.3390/ijms21072334)

* Vitamin D and the RNA transcriptome: more than mRNA regulation - May 2014 [Free PDF](https://doi.org/10.3389/fphys.2014.00181)

* LncRNA: a new player in 1α, 25(OH)2 vitamin D3/VDR protection against skin cancer formation - Feb 2014  **Daniel D. Bikle**  [Free PDF](%20https://doi.org/10.1111/exd.12341)

* Vitamin D and Non-coding RNAs: New Insights into the Regulation of Breast Cancer - March 2021 https://doi.org/10.2174/1566524020666200712182137  behind $68 paywall

</div>

Two percent or less of the genome is used to transcribe mRNAs encoding proteins. Nearly all the remainder is utilized in transcribing non coding RNAs, the bulk of which are RNAs at least 200 base in length,  **long non coding RNAs (lncRNA)** . Their number is estimated to be about 28,000, but only a small fraction of lncRNAs are well characterized. That said lncRNAs have been found to regulate a very diverse array of biochemical and genomic functions. One of the transcription factors found to be regulated by and to regulate lncRNA is the vitamin D receptor (VDR). Like lncRNAs VDR is involved in the regulation of numerous biochemical and genomic processes, so it is not surprising that there would be a number of interactions between lncRNAs and VDR in their diverse functions. However, the study of these interactions is in its infancy. 

To date most attention has been paid to their interactions in cancer. Our own studies have focused on non melanoma skin cancers, keratinocyte carcinomas to be precise. Deletion of VDR from keratinocytes predisposes them to malignant transformation. Among a number of potential mechanisms we found that VDR deletion from these cells alters the lncRNA profile to a more oncogenic configuration, increasing the expression of well known oncogenic lncRNAsa and decreasing the expression of well known tumor suppressor lncRNAs. Subsequent studies in other cancers have found similar associations between VDR and oncogenic lncRNAs with evidence of tumor specificity. To date these studies primarily reveal associations rather than causality, but causal links should be expected as research in this field continues to develop.

Key words: vitamin D vitamin D receptor keratinocytes cancer long non coding RNA genomics

#### References

1. Tragante V, Moore JH, Asselbergs FW. The ENCODE project and perspectives on pathways. Genet Epidemiol. 2014;38(4):275-80.

1. Bhan A, Soleimani M, Mandal SS. Long Noncoding  **RNA**  and Cancer: A New Paradigm. Cancer Res. 2017;77(15):3965-81.

   * This is an exellent review of the role of lnc **RNA** s in cancer

1. Cerase A, Pintacuda G, Tattermusch A, Avner P. Xist localization and function: new insights from multiple levels. Genome Biol. 2015;16:166.

1. Latos PA, Pauler FM, Koerner MV, Senergin HB, Hudson QJ, Stocsits RR, et al. Airn transcriptional overlap, but not its lnc **RNA**  products, induces imprinted Igf2r silencing. Science. 2012;338(6113):1469-72.

1. Engreitz JM, Haines JE, Perez EM, Munson G, Chen J, Kane M, et al. Local regulation of gene expression by lnc **RNA**  promoters, transcription and splicing. Nature. 2016;539(7629):452-5

   * This reference details mechanisms by which lnc **RNA** s regulate gene transcription

1. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, et al. A large intergenic noncoding  **RNA**  induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142(3):409-19.

1. Dimitrova N, Zamudio JR, Jong RM, Soukup D, Resnick R, Sarma K, et al. Linc **RNA** -p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint. Mol Cell. 2014;54(5):777 -90.

1. Kopp F, Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding  **RNA** s. Cell. 2018;172(3):393-407. 

   * This review describes the multiple and varied functions of lnc **RNA** s

1. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, et al. Long noncoding  **RNA**  as modular scaffold of histone modification complexes. Science. 2010;329(5992):689-93.

1. Portoso M, Ragazzini R, Brencic Z, Moiani A, Michaud A, Vassilev I, et al. PRC2 is dispensable for HOTAIR- mediated transcriptional repression. EMBO J. 2017;36(8):981-94.

1. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding  **RNA** s associated with SC35 splicing domains. BMC Genomics. 2007;8:39.

1. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding  **RNA** , and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031-41.

1. Fox AH, Lamond AI. Paraspeckles. Cold Spring Harb Perspect Biol. 2010;2(7):a000687.

1. West JA, Davis CP, Sunwoo H, Simon MD, Sadreyev RI, Wang PI, et al. The long noncoding  **RNA** s NEAT1 and MALAT1 bind active chromatin sites. Mol Cell. 2014;55(5):791-802.

1. Lee S, Kopp F, Chang TC, Sataluri A, Chen B, Sivakumar S, et al. Noncoding  **RNA**  NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. Cell. 2016;164(1-2):69-80.

1. Bikie dd. me Vitamin d Receptor as Tumor suppressor in SKin. Adv txp Med moi. 2020;丄268:285-306. 

   * This review describes different pathways by which the vitamin D receptor regulates tumor development in the skin.

1. Bikle DD. Vitamin D and cancer: the promise not yet fulfilled. Endocrine. 2014;46(1):29-38.

1. Bikle DD, Jiang Y, Nguyen T, Oda Y, Tu CL. Disruption of Vitamin D and Calcium Signaling in Keratinocytes Predisposes to Skin Cancer. Front Physiol. 2U16;7:296.

1. Teichert AE, Elalieh H, Elias PM, Welsh J, Bikle DD. Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice. The Jou **RNA** l of investigative dermatology. 2011;131(11):2289-97.

1. Zinser GM, Sundberg JP, Welsh J. Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis. Carcinogenesis. 2UU2;23(12):21U3-9.

1. Ellison TI, Smith MK, Gilliam AC, MacDonald PN. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. The Jou **RNA** l of investigative dermatology. 2008;128(1U):2508-17.

1. Gupta R, Dixon KM, Deo SS, Holliday CJ, Slater M, Halliday GM, et al. Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. The Jou **RNA** l of investigative dermatology. 2UU7;127(3):707-15.

1. Jiang YJ, Teichert AE, Fong F, Oda Y, Bikle DD. 1alpha,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the beta-catenin pathway. J Steroid Biochem Mol Biol. 2013;136:229-32.

1. Demetriou SK, Ona-Vu K, Teichert AE, Cleaver JE, Bikle DD, Oh DH. Vitamin D receptor mediates DNA repair and is UV inducible in intact epidermis but not in cultured keratinocytes. The Jou **RNA** l of investigative dermatology. 2012;132(8):2U97-1UU.

1. Jiang YJ, Bikle DD. Lnc **RNA**  profiling reveals new mechanism for VDR protection against skin cancer formation. J Steroid Biochem Mol Biol. 2U14;144 Pt A:87-90. 

   * This is the first demonstration that VDR regulates oncogenic and tumor suppressor Inc **RNA** s in mouse skin and human keratinocytes

1. Dinger ME, Pang KC, Mercer TR, Crowe ML, Grimmond SM, Mattick JS. NRED: a database of long noncoding  **RNA**  expression. Nucleic Acids Res. 2009;37(Database issue):D122-6.

1. Li X, Wu Z, Fu X, Han W. Long Noncoding  **RNA** s: Insights from Biological Features and Functions to Diseases. Medicinal research reviews. 2013;33(3):517-53.

1. Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, et al. Kcnq1ot1 antisense noncoding  **RNA**  mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell. 2008;32(2):232-46.

1. Ariel I, Ayesh S, Perlman EJ, Pizov G, Tanos V, Schneider T, et al. The product of the imprinted H19 gene is an oncofetal  **RNA** . Molecular pathology : MP. 1997;5U(1):34-44.

1. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, et al. The c-Myc oncogene directly induces the H19 noncoding  **RNA**  by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2UU6;66(1U):533U-7.

1. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, et al. The H19 non-coding  **RNA**  is essential for human tumor growth. PLoS One. 2UU7;2(9):e845.

1. Berteaux N, Lottin S, Monte D, Pinte S, Quatannens B, Coll J, et al. H19 m **RNA** -like noncoding  **RNA**  promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2UU5;28U(33):29625-36.

1. Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, et al. A long noncoding  **RNA**  maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472(7341):12U-4.

1. Ozes AR, Miller DF, Ozes ON, Fang F, Liu Y, Matei D, et al. NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene. 2016;35(41):535U-61.

1. Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang G, et al. Downregulation of long noncoding  **RNA**  MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol. 2015;8(5):4881-91.

1. Liu J, Peng WX, Mo YY, Luo D. MALAT1-mediated tumorigenesis. Front Biosci (Landmark Ed). 2017;22:66-80.

1. Moumen A, Magill C, Dry KL, Jackson SP. ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage. Cell cycle. 2013;12(4):698-704.

1. Redrup L, Branco MR, Perdeaux ER, Krueger C, Lewis A, Santos F, et al. The long noncoding  **RNA**  Kcnq1ot1 organises a lineage-specific nuclear domain for epigenetic gene silencing. Development. 2009;136(4):525-30.

1. Higashimoto K, Soejima H, Saito T, Okumura K, Mukai T. Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer. Cytogenetic and genome research. 2006;113(1-4):306-12.

1. Knoigni usKooei v, Geranpayen l, umrani md, GnaTouri-harc s. Assessment . expression of long noncoding  **RNA** s in vitamin D receptor signaling in breast cancer. Cancer Manag Res. 2018;10:3451- 62.

   * This study documented the association of VDR expression with that of a number of Inc **RNA** s in breast cancerbTunctio门ai vana门ts ana

1. Gheliji T, OsKooei VK, AshraTi HaTez A, Taheri M, GhaTouri-Fard S. Evaluation of expression of vitamin D receptor related Inc **RNA** s in lung cancer. Noncoding  **RNA**  Res. 2020;5(3):83-7.

   * This study documented the association of VDR expression with a Iarge number of Inc **RNA** s in Iung cancer

1. Mazdeh M, Zamani M, ETteKharian MM, KomaKi A, Arsang-Jang S, Taheri M, et al. Expression analysis oT vitamin D receptor-associated lnc **RNA** s in epileptic patients. Metab Brain Dis. 2019;34(5):1457-65.

1. Jin T, Guo Y, Huang Z, Zhang Q, Huang Z, Zhang Y, et al. Vitamin D inhibits the proliTeration oT Oral Squamous Cell Carcinoma by suppressing lnc **RNA**  LUCAT1 through the MAPK pathway. J Cancer. 2020;11(20):5971-81.

   * This study showed that the VDR ligand 1,25(OH)2D regulated the levels of numerous lnc **RNA** s in oral squamous cell cancer cell lines, but focused on LUCAT1.

1. Wang L, Zhou S, Guo B. Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non Coding  **RNA**  CCAT2. Int J Mol Sci. 2020;21(7).

1. Chen S, Bu D, Ma Y, Zhu J, Chen G, Sun L, et al. H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells. Neoplasia. 2017;19(3):226-36.

   * In this study whereas 1,25(OH2D could suppresss the expression H19, H19 could suppress VDR junction via the mi **RNA**  676-5p.

1. Fan W, Peng Y, Liang Z, Yang Y, Zhang J. A negative feedbacK loop oT H19/miR-675/EGR1 is involved in diabetic nephropathy by downregulating the expression oT the vitamin D receptor. J Cell Physiol. 2019;234(10):17505-13.

1. Zhang X, Ji S, Cai G, Pan Z, Han R, Yuan Y, et al. H19 Increases IL-17A/IL-23 Releases via Regulating VDR by Interacting with miR675-5p/miR22-5p in AnKylosing Spondylitis. Mol Ther Nucleic Acids. 2020;19:393-404.

1. Hou Q, Huang Y, Liu Y, Luo Y, Wang B, Deng R, et al. ProTiling the mi **RNA** -m **RNA** -lnc **RNA**  interaction networK in MSC osteoblast differentiation induced by (+)-cholesten-3-one. BMC Genomics. 2018;19(1):783.

1. Hou QK, Huang YQ, Luo YW, Wang B, Liu YM, Deng RD, et al. (+)-Cholesten-3-one induces osteogenic diTTerentiation of bone marrow mesenchymal stem cells by activating vitamin D receptor. Exp Ther Med. 2017;13(5):1841-9.